Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To determine whether the lipoxygenase metabolites of arachidonic acid, 5(S)-, 12(S)-, and 15(S)-hydroxyeicosatetraenoic acids [5(S)-HETE, 12(S)-HETE, and
15(S)-HETE
, respectively] are angiogenic, we have studied their effects on human dermal microvascular endothelial cell (HDMVEC) tube formation and migration. All three HETEs stimulated HDMVEC tube formation and migration. Because
15(S)-HETE
was found to be more potent than 5(S)-HETE and 12(S)-HETE in HDMVEC tube formation, we next focused on elucidation of the signaling mechanisms underlying its angiogenic activity.
15(S)-HETE
stimulated Akt and S6K1 phosphorylation in HDMVEC in a time-dependent manner. Wortmannin and LY294002, two specific inhibitors of phosphatidylinositol 3-kinase (PI3K), blocked both Akt and S6K1 phosphorylation, whereas rapamycin, a specific inhibitor of Akt downstream effector,
mammalian target of rapamycin
(
mTOR
), suppressed only S6K1 phosphorylation induced by
15(S)-HETE
suggesting that this eicosanoid activates the PI3K-Akt-
mTOR
-S6K1 signaling in HDMVEC. Wortmannin, LY294002, and rapamycin also inhibited
15(S)-HETE
-induced HDMVEC tube formation and migration. In addition, all three HETEs stimulated angiogenesis as measured by in vivo Matrigel plug assay with
15(S)-HETE
being more potent. Pharmacologic inhibition of PI3K-Akt-
mTOR
-S6K1 signaling completely suppressed
15(S)-HETE
-induced in vivo angiogenesis. Consistent with these observations, adenoviral-mediated expression of dominant-negative Akt also blocked
15(S)-HETE
-induced HDMVEC tube formation and migration and in vivo angiogenesis. Together, these results show for the first time that
15(S)-HETE
stimulates angiogenesis via activation of PI3K-Akt-
mTOR
-S6K1 signaling.
...
PMID:15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling. 1610 79
Chronic low-grade inflammation underlies obesity and associated metabolic dysfunctions. Lipoxygenase pathways are activated in adipose tissue during obese conditions. Since adipogenesis is associated with angiogenesis, the present study was designed to examine the role of 15-lipoxygenase metabolite, 15(S)-hydroxyeicosatetraenoic acid [
15(S)-HETE
] on angiogenesis in adipose tissue. Results showed that
15(S)-HETE
induced sprouting in fat pad stromovascular tissues, induced morphological changes relevant to angiogenesis in endothelial cells derived from adipose tissue, upregulated the production of CD31, upregulated the gene level expression and production of vascular endothelial growth factor (VEGF), indicating the pro-angiogenic effect of
15(S)-HETE
. LY294002, an inhibitor of PI3K-Akt pathway, and rapamycin, inhibitor of
mammalian target of rapamycin
(
mTOR
), significantly reversed the effect of
15(S)-HETE
.
15(S)-HETE
also induced activation of Akt and
mTOR
. These observations suggest that
15(S)-HETE
stimulates angiogenesis in adipose tissue through activation of PI3K/Akt/
mTOR
signaling.
...
PMID:15(S)-HETE-induced angiogenesis in adipose tissue is mediated through activation of PI3K/Akt/mTOR signaling pathway. 2421 92